These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27587542)

  • 21. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.
    Keshavjee S; Gelmanova IY; Farmer PE; Mishustin SP; Strelis AK; Andreev YG; Pasechnikov AD; Atwood S; Mukherjee JS; Rich ML; Furin JJ; Nardell EA; Kim JY; Shin SS
    Lancet; 2008 Oct; 372(9647):1403-9. PubMed ID: 18723218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DOTS and DOTS-plus: not the only answer.
    Farmer P
    Ann N Y Acad Sci; 2001 Dec; 953():165-84. PubMed ID: 11795410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TB "hot zones" emerging.
    Public Health Rep; 1998; 113(2):107. PubMed ID: 9719808
    [No Abstract]   [Full Text] [Related]  

  • 24. [Difficulties in the treatment of pulmonary tuberculosis in children].
    Brînză N; Mihăescu T
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):852-5. PubMed ID: 18389769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug-resistant tuberculosis in the Republic of Karelia].
    Markelov IuM; Dorodnaia IA
    Probl Tuberk Bolezn Legk; 2007; (8):8-10. PubMed ID: 17915460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
    Bang D; Lillebaek T; Thomsen VØ; Andersen AB
    Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis].
    Grishin MN; Svistov VV; Krivoshein IuS
    Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom.
    Williams B; Ramroop S; Shah P; Anderson L; Das S; Riddell A; Liebeschuetz S; Bernatoniene J; Shingadia D; Kampmann B
    Pediatr Infect Dis J; 2013 Aug; 32(8):926-7. PubMed ID: 23856715
    [No Abstract]   [Full Text] [Related]  

  • 29. Childhood multi-drug resistant tuberculosis with paradoxical granulomas - role of steroids.
    Shah I; Goyal A
    Infect Dis (Lond); 2016; 48(11-12):862-3. PubMed ID: 27376454
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome.
    Keshavjee S; Gelmanova IY; Shin SS; Mishustin SP; Andreev YG; Atwood S; Furin JJ; Miller A
    Int J Tuberc Lung Dis; 2012 May; 16(5):596-603. PubMed ID: 22410436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug-resistant tuberculosis: a review of the 23 cases treated by the Saint-Pierre University Hospital (Brussels).
    Jacob V; Robert L; Lebrun C; Van Laethem Y; Sergysels R
    Acta Clin Belg; 2009; 64(2):113-9. PubMed ID: 19432023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug treatment options for multidrug-resistant tuberculosis.
    Patel K
    Conn Med; 1994 Apr; 58(4):227-30. PubMed ID: 8045123
    [No Abstract]   [Full Text] [Related]  

  • 33. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.
    Chiang CY; Caminero JA; Enarson DA
    Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184
    [No Abstract]   [Full Text] [Related]  

  • 34. [Renaissance of tuberculosis?].
    Meyer FJ; Konietzko N
    Internist (Berl); 1995 Dec; 36(12):1162-73. PubMed ID: 8567222
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of relapse and failure after retreatment with the Category II regimen in Nepal.
    Yoshiyama T; Shrestha B; Maharjan B
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1418-23. PubMed ID: 20937181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-resistant tuberculosis in children.
    Schaaf HS
    S Afr Med J; 2007 Oct; 97(10 Pt 2):995-7. PubMed ID: 18000589
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A; Klugman KP; Cohen C; Wolter N; de Gouveia L; du Plessis M; Mpembe R; Quan V; Whitelaw A; Hoffmann R; Govender N; Meiring S; Smith AM; Schrag S;
    Lancet; 2008 Mar; 371(9618):1108-13. PubMed ID: 18359074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.
    Shin SS; Pasechnikov AD; Gelmanova IY; Peremitin GG; Strelis AK; Mishustin S; Barnashov A; Karpeichik Y; Andreev YG; Golubchikova VT; Tonkel TP; Yanova GV; Yedilbayev A; Rich ML; Mukherjee JS; Furin JJ; Atwood S; Farmer PE; Keshavjee S
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1314-20. PubMed ID: 18034952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug-resistant tuberculosis in UK children: presentation, management and outcome.
    Williams B; Ramroop S; Shah P; Anderson L; Das S; Riddell A; Liebeschuetz S; Basu Roy R; O'Callaghan M; Sloper K; Bernatoniene J; Shingadia D; Kampmann B
    Eur Respir J; 2013 Jun; 41(6):1456-8. PubMed ID: 23728407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.